This compound is a fluorinated, iodinated pyrimidinedione derivative used as a pharmaceutical intermediate. Its structure features a pyrimidine ring with iodine and methyl substituents, linked to a difluorinated benzyl group bearing a trifluoromethyl moiety.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 1150560-54-5
5-bromo-1-{[2-fluoro-6-(trifluoromethyl)phenyl]methyl}-6-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione
Pharmaceutical intermediate
5-(2-Fluoro-3-methoxyphenyl)-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-6-methyl-2,4(1h,3h)-pyrimidinedione
Pharmaceutical intermediate
2-(2-(((Benzyloxy)carbonyl)amino)thiazol-4-yl)-5-((3-methylbut-2-en-1-yl)oxy)-5-oxopent-2-enoic acid
pharmaceutical intermediate
Ethyl 3-oxo-4-(2,4,5-trifluorophenyl)butanoate
Pharmaceutical intermediate
5-BROMO-2,3-DIHYDRO-7-AZAINDOLE
pharmaceutical intermediate
1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-6-methylpyrimidine-2,4-dione
Pharmaceutical intermediate
Alogliptin impurity
Pharmaceutical impurity reference standard
2-((6-Chloro-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile
research compound
1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-5-iodo-6-methylpyrimidine-2,4-dione
TZBUKGISILNJCR-UHFFFAOYSA-N
CC1=C(C(=O)NC(=O)N1CC2=C(C=CC=C2F)C(F)(F)F)I
—